TradFi Terminal › Markets › HIMS
Hims & Hers Health (HIMS) stock perp on Hyperliquid
Trade HIMS 24/7 on Hyperliquid with a live chart, one-click order buttons and a sub-second news feed. Loading the live terminal…
| Price | $29.295 |
|---|---|
| 24h change | +4.80% |
| Funding (1h) | +0.0006% |
| Open interest | $1.6M |
| 24h volume | $2.9M |
| Max leverage | 10x |
Latest HIMS news
- — Health Brief: RFK Jr. opens the door to peptides - WAPO
- — A Ballot-Stacking Effort in Alaska - NYT
- — Health Care Up as Traders Slough Off Earnings -- Health Care Roundup - WSJ
- — Tracking Trump: Fed keeps interest rates steady; Iran war cost update; RFK Jr.'s peptide plan; and more - WAPO
- — [twt] andrewdudum: HHS just took a step toward the exact future that we’ve built for – bringing peptides out of the gray market, with clinician oversight and quality starting at the source. We’ve taken it one step further by building a US-based supply chain and infrastructure that our customers can trust. This is encouraging progress. More to come.
- — [twt] sarahkarlin: Basically our entire system for reviewing and approving drugs was blown up because the current Health Secretary and his buddies like these products.
- — Citing 'safety' and 'freedom,' HHS will allow compounding of certain wellness peptides - ENDPOINTSNEWS
- — FDA scientists opposed the Trump administration's effort to ease peptides access - ABC NEWS
- — FDA scientists opposed the Trump administration's effort to ease peptides access - AP
- — [twt] oraclenyse: $HIMS Supplements brand Rho Nutrition explores sale, sources say Reuters
- — [twt] oraclenyse: $HIMS WHITE HOUSE CLEARS FDA'S NEW PEPTIDE COMPOUNDING POLICY FOR RELEASE FOLLOWING REVISIONS; FDA COULD PUBLISH NEW RULES AT ANY TIME — OIRA
Headlines are delayed. Sign in for real-time news.
More markets
SKHX · GOOGL · CL · SP500 · MU · XYZ100 · SKHY · SOXL · SNDK · DRAM · BRENTOIL · SILVER · SPCX · NVDA · SMSN · INTC · META · UNITREE · MSFT · MRVL · KORU · NBIS · AMD · TSLA · all markets